NASDAQ:CELZ
Creative Medical Technology Holdings, Inc.
Creative Medical Technology Holdings, Inc.'s revenue fell 45.5% in fiscal 2025 to $6,000 while operating margin fell to −102380.2%, its lowest in 9 years. The diluted share count rose 61.0%.Summary generated from Creative Medical Technology Holdings, Inc.'s SEC filings. Latest annual report filed Mar 20, 2026.
Key statistics
Fiscal 2025 from SEC filings. MethodologyRevenue (FY25)$6,000
Revenue growth−45.5%
Revenue, 5-yr CAGR−48.4%
Gross margin63.4%
Operating margin−102380.2%
Net margin−99916.8%
ROICn/a
Return on equity−86.5%
Debt / equityn/a
Free cash flown/a
FCF marginn/a
Share count change+61.0%
Financials
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating income | −3 | −10 | −6 | −6 | −6 |
| Net income | 19 | −10 | −5 | −5 | −6 |
| Free cash flow | n/a | n/a | n/a | n/a | n/a |
Recent filings
- 4Insider transaction report
Sep 25, 2026 - 8-KEntry into a material agreement
Sep 25, 2026 - 8-KAmendment to articles or bylaws
Aug 31, 2026 - 10-QQuarterly report for the period ended Jun 30, 2026
Aug 7, 2026 - DEF 14AProxy statement
Jul 14, 2026 - 8-KEntry into a material agreement
Jul 2, 2026 - S-1Registration statement
Jun 25, 2026 - 10-QQuarterly report for the period ended Mar 31, 2026
May 8, 2026